567-Patient Study Confirms LMWH Safety in Pregnancy
Flora Peyvandi, former President of ISTH, recently shared an insightful post on X:
”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study.”
Read the full article here.
An article ”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study”, published by Camille Simard et al. in the Journal of Thrombosis and Haemostasis, sheds light on the safety use of low-molecular-weight heparin (LMWH) in pregnancy complicated by acute venous throembolism.
This multinational (Germany;Quebec) cohort study of 567 pregnant women with VTE treated with LMWH provided new data on bleeding risk during pregnancy.
The findings suggest that LMWH type and dosing frequency may not significantly impact bleeding risk, though further research is needed to refine anticoagulation strategies for optimizing maternal outcomes.
More on scientific advancements in the field of thrombosis featured in Hemostasis Today.
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026